Bolsonaro says he will not buy Chinese Sinovac vaccine

(EFE) – Brazilian President Jair Bolsonaro affirmed this Wednesday that his Government will not buy the coronavirus vaccine developed by the Chinese company Sinovac and disavowed its Minister of Health, Eduareo Pazuello, who the day before announced the purchase of 46 million doses of the immunizer.

The head of state affirmed in messages on social networks that the Government you cannot commit to buying a vaccine whose efficacy and safety has not been proven previously by the Ministry of Health or certified by the National Health Surveillance Agency (Anvisa).

His refusal came a day after Pazuello, an Army general who took over as Bolsonaro’s third minister during the pandemic, announce an agreement to buy 46 million doses of the so-called vaccine “Coronavac for 427 million dollars.

The “Coronavac” It is developed and experienced in Brazil by Sinovac in association with the Butantan Institute, a scientific institution linked to the state of Sao Paulo, whose governor, Joao Doria, is a major political rival of Bolsonaro.

“The Brazilian people will not be anyone’s guinea pig. A billionaire financial contribution is not justified in a medicine that did not even pass the testing phase, “said the head of state in a comment on his social networks and in which, by making it clear that his decision has a political connotation, he referred to Coronavac as “The Chinese vaccine of Joao Doria”.

Read also: Bolsonaro assures that the vaccine for the coronavirus “will not be mandatory” in Brazil

“For my Government, any vaccine, before being made available to the population, has to be scientifically proven by the Ministry of Health and certified by Anvisa,” he added before making it clear that, given the above, “My decision is not to purchase the aforementioned vaccine.”

After a meeting on Tuesday with different governors, including Doria, Pazuello affirmed that he had signed a protocol of intentions to acquire Chinese medicine and expand the offer of vaccines against the coronavirus that will be offered to Brazilians.

The Government had already agreed with the company AstraZeneca and the University of Oxford to purchase 100 million doses of the vaccine that both are developing, and also joined the Covax initiative of the World Health Organization (WHO) to award another 40 million doses

The minister clarified that both the Sinovac and Oxford vaccines are still in the testing period and that, before being supplied, they must be certified by Anvisa.

The two vaccines are massively tested in Brazil, the second country with the most deaths from COVID-19 in the world after the United States, with 155,000 deaths, and the third with the most cases after the US and India, with 5.3 million infections.

No intention to purchase “Chinese Vaccines”

After Bolsonaro’s refusal, the Vice Minister of Health, Elcio Franco, in an attempt to minimize the disavowal of Pazuello, stated in a statement on television that for now “There is no intention to purchase Chinese vaccines.”

According to the vice minister, “there was a wrong interpretation of what the minister said, since at no time was the vaccine approved.”

Franco affirmed that the protocol of intentions signed by Pazuello to buy 46 million vaccines from the Butantan Institute is not binding and that it was signed “because it is an important partner of the Ministry of Health in the production of vaccines for the National Immunization Program.” .

Read also: Independence in Brazil: Bolsonaro leads an act of 500 people without a mask or prevention measures

He added that it was another “Initiative to try to offer safe and effective vaccines to the Brazilian population” but that will only be launched in the event of a delay in the project to produce the Oxford vaccine in Brazil.

“The premise to acquire any vaccine is based on safety, efficacy, scale production and a fair price. Any vaccine, when available, certified by Anvisa and purchased by the Ministry, will be offered to Brazilians by the National Immunization Program. And, as it depends on this portfolio, it will not be mandatory, “he said.


Government Urgently Urged To Covid-19 Vaccination Page all – Indonesian Society of Internal Medicine Specialists ( PAPDI) asked the government not to rush the Covid-19 vaccination.

This statement was conveyed by PAPDI in a letter of recommendation uploaded via the official Twitter of the Indonesian Doctors Association (PB IDI) Executive Board.

When confirmed, the Secretary General of PAPDI Eka Ginanjar confirmed the letter.

“Yes, that’s right,” said Eka when contacted, Thursday (22/10/2020).

In the recommendation letter, PAPDI supports all government efforts in fighting the corona virus pandemic in Indonesia, including the vaccination program.

PAPDI also thanked the government for procurement the Covid-19 vaccine for the community.

“We are grateful to the government for trying to make this vaccine available for the public, including health workers,” wrote PAPDI in his letter.

Also read: Teachers, Station Employees, and Fire Fighters Are Also Priority Recipients of Covid-19 Vaccines in Bekasi

Ensure vaccine safety

However, PAPDI requested that the Covid-19 vaccine to be used must have proven its effectiveness, safety and immunogenicity through clinical trials according to the stages of developing a new vaccine.

This step was taken to achieve good results from the corona virus vaccination program.

To achieve this goal, PAPDI recommends that the government does not rush the vaccination efforts.

While waiting, the government can continue to remind the public to stick to health protocols.

IDI PB Recommendations

The Executive Board of the Indonesian Doctors Association (IDI) also issued a letter containing attitudes and recommendations regarding the Covid-19 vaccination plan.

In his letter, one of the points conveyed by IDI was that good preparation was needed in terms of selecting the type of vaccine to be provided.

In addition, it also needs to be prepared for its implementation.

IDI emphasized, in choosing the type of vaccine, there are absolute conditions that must be met, namely the vaccine to be used has proven effectiveness and immunogenicity, as well as its safety which is proven through the published results of phase 3 clinical trials.

According to IDI, the Sinovac vaccine trial in Barzil has been completed on 9,000 volunteers. However, the results will only come out after completing the vaccination test of 15,000 other volunteers.

IDI said that there is an element of caution from other countries while waiting for more data from the results of phase 3 clinical trials. Vaccination is an important program, but it cannot be done in a hurry.

Also read: Claimed to be Safe, China’s CNBG Coronavirus Vaccine is Offered Free for Students

Receive the vaccine in November 2020

As of Wednesday (21/10/2020), Indonesia has reported 373,109 cases of infection with 12,857 deaths and 297,509 patients declared cured.

The government plans to start receiving the vaccine in November 2020.

A number of preparations have also been made, including selecting health facilities for the administration of the vaccine.

The Director General of Disease Prevention and Control of the Ministry of Health of the Republic of Indonesia, Dr. Achmad Yurianto, said that there are three vaccines that have been purchased by the government because they have passed phase three clinical trials and are expected to be given to the Indonesian people.

The three vaccines in question are the Sinovac, Sinopharm, and Cansino vaccines which have also been tested in several countries.

According to Yuri, Indonesia only needs vaccination as much as 70 percent of the total population to achieve community immunity or herd immunity.

“Well, this basis is what we then use, that our calculations only reach at herd immunity, meaning about 160 million people (who need to be vaccinated), “he said.

Also read: Once terminated, the AstraZeneca Corona Vaccine Trial Will Continue Bhayu Tamtomo
Infographics: Priority List of Recipients Covid-19 Vaccine


Brazil Trials BCG TB Vaccine to Fight Covid-19

TEMPO.CO, Rio de Janeiro – Brazil on Monday, 19 October 2020, began testing the effectiveness of the Bacillus Calmette-Guerin (BCG) tuberculosis (TB) vaccine to treat patients Covid-19.

The state-run research center, the Oswaldo Cruz Foundation (Fiocruz), started testing health workers after vaccine it is known to prove effective in reducing respiratory tract infections, according to Brazil’s national news agency Agencia.

For the initial phase, the vaccine will be tested on 2,000 volunteers in Campo Grande, the capital of Mato Grosso do Sul State, and 1,000 other volunteers in Rio de Janeiro.

The testing is part of a phase 3 clinical trial conducted to assess whether BCG vaccination can reduce the impact of Covid-19 on health workers, the group most exposed to the virus.

Apart from 3,000 Brazilian volunteers, 7,000 volunteers in Australia, UK, Spain and the Netherlands will also take part in the trial, and all of them will be monitored for one year.

The BCG vaccine is one of the most widely used vaccines in the world, given annually to around 120 million newborns. Several studies have shown this vaccine is effective for infections other than tuberculosis.

Fiocruz revealed a clinical study conducted in Greece showing its use vaksin BCG in the elderly (elderly) can reduce respiratory infections by 79 percent during one year of follow-up.



Bio Farma Flooded Fresh Funds Bill Gates For Vaccines

Jakarta, CNN Indonesia –

Bio Farma said it received funding from a humanitarian organization owned by the founder of Microsoft Bill Gates, Bill & Melinda Gates Foundation to discover polio vaccine latest (nOPV).

Director of Bio Farma, Honesti Basyir, said that currently his party is processing the polio vaccine at the World Health Organization (WHO) to obtain Emergency Use Listing (EUL) permits.

“They provide sponsorship to bio-pharmacy to find the latest polio vaccine and are currently in the process at WHO in a kind of EUL which is similar to Emergency Use Authorization (EUA),” Honesti said in a virtual conference, Wednesday (21/10).

Honesti also said that Bio Farma is the only vaccine producing company that can produce this latest polio vaccine.

Research on the latest generation of polio vaccine (nOPV) includes the development of vaccine technology, Clinical Trials, stages 1-3, to the production process.

“Bio Farma is also the only vaccine producer company that can produce this latest polio vaccine,” said Honesti.

The Bill and Melinda Gates Foundation has indeed played a role in providing solutions related to child health in Indonesia.

Previously, Minister of Finance Sri Mulyani in the 2018 IMF-World Bank Group Annual Meeting, Bill & Melinda Gates Foundation said that they would assist research at State-Owned Enterprises (BUMN) through Bio Farma for vaccine development.

The aim is that the related vaccine types are not only produced by Western countries. It is hoped that Indonesia will have the capacity so that it can become a world-class player in the field of vaccine production.

(jnp / DAL)

[Gambas:Video CNN]


Researchers want to speed up vaccine development, coronavirus infects volunteers

The British research team announced its intention to deliberately spread the coronavirus among volunteers in the world. This method is considered by many to be risky and unethical. Even in a healthy person, it is not possible to predict with certainty how he will deal with the disease.

However, according to scientists, taking such a risk is desirable, he writes AP agency. If the plan succeeds, the result could be a groundbreaking study to help develop the vaccine. Dozens of companies are working on it, and the findings of the researchers could help determine which will work best for Covid-19.

“Deliberately infecting volunteers with a known human pathogen is never taken lightly,” said Peter Openshaw, a Royal University professor at London. “However, these studies are fundamentally helping to uncover new insights into the disease. This is also true of Covid-19, which is being addressed around the world,” he added.

More than a million people worldwide have succumbed to coronavirus. Therefore, according to the research team, any attempt to speed up the marketing of the vaccine is appropriate.

The University of London will contact the Ministry of Trade, Energy and Industrial Strategy, the Royal Free London NHS Foundation Trust and the research company hVIVO to carry out the study. The British government wants to invest over 33 million pounds, almost a billion crowns, in the project.

The same approach has been used in the past to develop vaccines against diseases such as typhus, cholera or malaria.


Vaccines Are Given to Healthy People Who Are Not Infected


Handling Task Force COVID-19 talk about the groups that will be vaccinated against COVID-19. The spokesperson for the COVID-19 Handling Task Force Prof. Wiku Adisasmito stated, one of the criteria for getting the vaccine is a healthy person.

“In principle, vaccination given to healthy people who have not been infected to protect themselves. Those who are given a high risk of contracting must be given it first, “said Prof. Wiku in a press release on YouTube BNPB, Monday (19/10/2020).

Prof. Wiku also conveyed that the priority groups for vaccine recipients are those who are at high risk. Among them are health workers and public service workers.

On this occasion, he also explained the difference between vaccination and immunization. In general, vaccination is the process of getting a vaccine and immunization is the result of vaccination, namely gaining immunity.

“If vaccination puts the vaccine into the body, immunization is a process in which the body can generate immunity due to the formation of specific antibodies against the targeted disease,” he concluded.

Watch Video “Corona Vaccine is Not Recommended for Children and Pregnant Women
[Gambas:Video 20detik]
(kna / up)


Flu Vaccine: 11 Side Effects You Should Know About

As a runner, your goal is to stay in top shape at all times, whether it’s to prevent a nagging injury from setting you on the sidelines or to keep you away from an illness like a cold or flu. And, since flu season has come, getting the flu shot is an important step in running at your best during the winter months.

But every year a question arises: Can the flu shot make you sick? No, doctors argue. However, like any other vaccine or medicine, it can have side effects. The arm may be sensitive after the flu shot, or the child may develop a cough after taking a dose of the nasal vaccine.

“Most patients have no side effects,” says Sandra Kemmerly, MD, medical director of the hospital quality system at Ochsner Health System of New Orleans. And when symptoms do show up, they’re usually mild and go away in a day or two, she says.

Then Why do some people feel sick after the flu shot, while others don’t? Doctors say reactions to the flu vaccine differ from person to person and that multiple factors are likely at play.

Think about how people respond to the common cold. Some people have a runny nose and go on with their life, while others stay at home with a fever or develop a cough. The same goes for the flu shot, says Claudia Vicetti, MD, a pediatric infectious disease specialist with UnityPoint Health in Cedar Falls, Iowa. “You are stimulating your body and your immune system can react in different ways.”

Moreover, the minor side effects are nothing compared to how dangerous the flu can be. During last year’s season, between October 2019 and April 2020, according to preliminary estimates by the Centers for Disease Control and Disease Prevention (CDC), up to 62,000 people died from flu complications.

This is why it is so important to get vaccinated every year. “The flu” is not a single virus. Each season a new vaccine is developed that adapts to the strains in circulation. Getting a flu shot may protect against the same virus or related viruses in the vaccine, but it doesn’t cover all possible strains a person might encounter, explains the CDC.

This year’s vaccine will focus on the following strains:

  • A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09-like virus
  • A/Hong Kong/2671/2019 (H3N2) – come virus
  • B / Washington / 02/2019 (lineage B / Victoria) -like virus

While not 100% effective, the flu shot is the best way to protect yourself from the disease and can greatly reduce the chances of ending up in hospital.. It is important to get vaccinated before the end of October, so your body has time to develop immunity, especially this year, as the new coronavirus and the flu circulate at the same time. The CDC says protecting yourself from the flu this season is “more important than ever,” and this may help reduce strain on health systems that are responding to the COVID-19 pandemic.

Once the vaccine is given, you may be one of the few who feels a little dejected afterwards, but that state shouldn’t last very long.

Here are the side effects of the flu shot to know when you should and shouldn’t worry, and how to feel better when hit by the side effects.


The Covid-19 vaccine in production in Belgium: this is what it looks like

** ********** ** ****** ** ** ***** ********* ******** * ********* *** ***** ***************

**** **** ***** **** ** ******* *** ** ***** ********** *** * ********* ** *********** ***** ***** ********* **************** **** ****** *** ********* *** ********** *********** **** ***** *** ******** ** ********** ** ****** *************** * **** ***** *********

*** ********** ************ **************** ****** ***** ** *** ** *****************

** *** ************* ******** *********** ** ******** ************* ********* *** ************ ******** *** ** ********** ** ******** ***** *** *** ****** ***** ****** ******* ** ******* ******* ** ******* *** ****** ** ****** *** *** **** *** ****** ******* ****** *** *** ** ******* *** ******** ******** ** *** ** ************* **** ** *** ** **** *** ** ******** ******** ****** ***********

******** *** ** ***************

** ****** *** *** *** *** ** ******** *** ***** ** *** ** ********* **** ** **** *** **** **** ** ***** **** ********* ** ************ ** *********** *** ****** **** ******** **** ***** ***************** ******* ** ***** ***** **** ***********

*** ********** ** *********** **** **** ** ****** ** ********

** ****** **** ********* ******* **** **** **** ***** ********** **** *** ******** *** ** ***** ***** *********** ****** *** ** **** *** ********* ********* ** ******** ***** **** ****** ** ************** ****** ******** * ************ *** *************** **** **** **** ***** ********** ** **** *** *** *********** ** *** ********* ******* ********** **** ****** ** ******* ****** ********* ** ******* ** ** *********** **** **** ** ** **** *** ** **** ***** ** ******* ** ****

** ******** **** ********** *** ****** ************

*** ********* **** ********* ***** ********** *** ***** **** ** ** **** *** **** **** *** ***** ** **** **** ** *******

*** **** *** ******* ************ ** ********* ** ********* ********* ******* ************* ***** ****** *** ******** **********************

*** ********* **** ******** ** ****** ********** ** ******** **** ***** ** ** ***** ** ********* ***** ********* *** ********* ** **** ** *********** ********** ********** **** ******* *** ** ********* ** ******* ************* ** *** ****** **** ********** ***** ****** ** ****** ** ***** ****** ******* ** **** *** *** ******** **** ****** *** *** ** ***** ** *********** ** ******** ********* **** **** *** ***************** ** ** ** **** ****

**** ***** *** ** ****** *** *** **** *** ****** ******* ** **** *** ** ******* ** *** ******* ************* ********* *** ************

*** ****** ** **** *** ******* ** **** ** **************** ** ****** ** ********* ** ********* ** ***** ** ********** **** ******** **** ** ** **** *** ****** **** **** ** ****** ** *********** ** ******* *** ***** ******* * **** ** ****** *** ****** ****** ************* *************** ********** ** ****** ** ********* ********* ** ***** ** ********* ** ** ******** ** *** ** ******** ******* **** ***** ** ******** *** *** **********

****** ******* ** ***** ******* ******* ****************

** ** ******* ******** ********* ***** ** ***** ** ******** **** ** ****** ** ****** ****** ******** **** ** ***** **** ***** ** ******* ************* ** ****** **** ** ********* *** ************ *** ******* **** ***** ** ****** ** ********* *** ** ****** ********* **** **** ** ****** ******** ********** ******* **** ** ****** ******** ** ******** ***** ***** ** ***** ******* *******

*** ******* ****** ** ******** **** * *************

******** ** ***** ******** **** ******* **** ***** **** ***** ** ****** *** ******* ************


Good News, Khofifah Called East Java Priority to Get Covid-19 Vaccines

MANTRA SUKABUMI – Governor East Java Khofifah Indar Parawansa conveying related good news vaccine Covid-19.

Khofifah said that Province East Java become one of three provinces in Indonesia that will be prioritized for getting vaccines Covid-19 from the Central Government.

It’s just that, Khofifah is still waiting for the decision of the Central Government because of the news vaccine will come in November 2020 later.

Also Read: Gatot Nurmantyo speaks out regarding Jokowi’s removal: I am already an ordinary citizen, retired from the army

Also Read: The Ministry of Manpower suddenly asks workers to return the BLT BPJS Employment Funds that have been disbursed, what’s going on?

“If vaccine we are waiting for the Central Government. I’m listening, East Java three Province who will get priority, “he said as quoted by from RRI on Sunday, October 18, 2020.

Therefore, Khofifah asked the people of East Java to be patient regarding this good news. He also promised if East Java officially get a quota amount vaccine in writing from the Central Government, will be conveyed to the public

“Later, after clearing, we will get a written letter East Java how many vaccine, then we can convey in detail, “he continued.

In addition, the spread of cases Covid-19 in East Java, the total number of positive confirmations was 48,690 cases, 2,706 people were treated or about 5.56%, while patients recovered were 42,455 or 87.19%, and 3,529 cases died or 7.25%.


The Latest News About Sinovac Covid-19 Vaccine Test in Bandung

Jakarta, CNBC Indonesia – PT Bio Farma (Persero) has completed injecting the Covid-19 vaccine into 1,620 Covid-19 vaccine volunteers who are subject to the third phase of clinical trials. The next step is giving the second injection and observing the vaccine’s efficacy / efficacy and safety to the subject.

Director of Bio Farma Honesti Basyir said the vaccination program which is targeted to be implemented next year for 170 million people or around 60% of the total population of Indonesia must be properly guarded.

So that the entire process must be well managed from the start, starting from the phase 3 clinical trial, production to distribution from Bio Farma, from the provincial level to the health center level, including health workers who provide the Covid-19 vaccine to the community.

“Therefore, this Covid-19 vaccination program must be best guarded as possible from all stakeholders, so that this program can run according to procedures, and also be executed so that later the public is sure that the Covid-19 vaccine that will be given to the community is in accordance with the regulations of the Agency. POM will ultimately be able to stop the spread of the Covid-19 virus, “Honesti said in a press release, quoted on Sunday (18/10/2020).

Under surveillance carried out by the POM, until the last injection of the subject last week, there were no reports of Post-Immunization Follow-Up Incidents (AEFI) or serious or serious side effects among Covid-19 vaccine volunteers.

Director of Drug Registration at POM, Riska Andalusia, said that the POM has a supervisory and advisory function in the clinical trial process currently taking place. The results of this clinical trial in Bandung will later be combined with phase three clinical trials from Brazil, Chille, Turkey and Bangladesh for this CoronaVac vaccine.

After the phase 3 clinical trial is complete, the Covid-19 vaccine will be produced by Bio Farma, and of course in this production process it must meet the quality / quality aspects and Bio Farma will still be under the supervision of the POM Agency to comply with the Good Manufacturing Practices regulations. Good medicine.

“These three aspects, efficacy, safety and quality, must be fulfilled by Bio Farma, as a registrant for the Covid-19 vaccine to be declared feasible or not by the POM to produce and distribute,” said Riska.

Furthermore, the Head of POM RI Penny K. Lukito stated that the assistance provided by the institution he leads is expected to accelerate the process of issuing an Emergency Use Authorization (EUA) for the vaccine later.

During the period of injecting vaccines to all subjects in Bandung, the POM stated that there were no excessive reactions or Serious Adverse Events, only mild reactions such as in general immunization.

“Furthermore, the POM will carry out regular monitoring to obtain complete data on the efficacy and safety of vaccines required for EUA administration,” said Penny in a separate statement.

He revealed that clinical trials are an important stage in research / development to obtain valid efficacy and safety data to support the Covid-19 vaccine registration process.